CLINICAL_TRIALS
research
· 2011-10-03
Clinical Trial Update: Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker [NA]
Summary
This clinical trial update describes changes after replacing ACE inhibitors with an angiotensin II receptor blocker in hypertension, with the current status ind…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Slovak Academy of Sciences | Conditions: Hypertension | NA | Status: UNKNOWN